Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07369284 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Melatonin for Glycemic Control in Gestational Diabetes Mellitus

Study acronym: MELODY
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this randomized, double-blind, placebo-controlled clinical trial is to evaluate whether melatonin supplementation improves glycemic control in pregnant women diagnosed with gestational diabetes mellitus (GDM). The main question it aims to answer is: Does melatonin supplementation help with glycemic control, especially in lowering fasting plasma glucose level? Researchers will compare melatonin to a placebo (a look-alike substance that contains no melatonin) to see if melatonin works to improve glycemic control. Participants will: 1. Take melatonin or a placebo every day after randomization until delivery 2. Visit the antenatal clinic once every 1 to 2 weeks for follow-ups
Trial Details
NCT Number NCT07369284
Lead Sponsor Obstetrics & Gynecology Hospital of Fudan University
Collaborators: West China Second University Hospital
Conditions
(from sponsor)		 Gestational Diabetes
Related terms Diabetes, Gestational
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov